Cytokine expression by cultured osteoblasts from patients with osteoporotic fractures

International Journal of Experimental Pathology

Volumn 81, Issue 2, 2000, Pages 159-163

  Walsh, C A ^a   Birch, Mark A ^a   Fraser, William D ^b   Ginty, Andrew F ^a   Gallagher, James A ^c  

^a LIVERPOOL HOPE UNIVERSITY   (United Kingdom)

^b ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Cultured human osteoblasts; Cytokines; Osteoporosis

Indexed keywords

CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 3; INTERLEUKIN 6; INTERLEUKIN 8; LYMPHOTOXIN; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

BONE MASS; CELL CULTURE; FRACTURE; GENE EXPRESSION; HUMAN; HUMAN CELL; OSTEOARTHRITIS; OSTEOBLAST; OSTEOPOROSIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW;

EID: 0034017735     PISSN: 09599673     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2613.2000.00147.x     Document Type: Review

References (22)

1. AMMANN P., GARCIA I., RIZZOLI R., MEYER J.-M., VASSALLI P. & BONJOUR J.-P. (1995) Transgenic mice expressing high levels of soluble tumour necrosis factor receptor-1 fusion protein are protected from bone loss caused by oestrogen deficiency J. Bone Miner. Res. 10 (Suppl.), S139.
2. BERESFORD J.N., GALLAGHER J.A. & RUSSELL R.G.G. (1986) 1,25-Dihydroxyvitamin D3 and human bone-derived cells in vitro: effects on alkaline phosphatase, type I collagen and proliferation. Endocrinol. 119, 1776-1785.
3. BERTOLINI D.R., NEDWIN G.E., BRINGMAN T.S., SMITH D.D. & MUNDY G.R. (1986) Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors. Nature 319, 516-518.
4. BIRCH M.A., GINTY A.F., WALSH C.A., FRASER W.D., GALLAGHER J.A. & BILBE G. (1993) PCR detection of cytokines in normal human and pagetic osteoblast-like cells. J. Bone Miner. Res. 8, 1155-1162.
5. CHAUDHARY L., SPELSBERG T.C. & RIGGS B.L. (1992) Production of various cytokines by normal human osteoblast-like cells in response to interleukin-1β and tumour necrosis factor-α: lack of regulation by 17β-estradiol. Endocrinol. 130, 2528-2534.
6. CHOMCZYNSKI P. & SACCHI N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159.
7. GALLAGHER J.A., GUNDLE R. & BERESFORD J.N. (1996) Isolation and culture of osteoblastic Cells from Human Bone. In Human Cell Culture Protocols. Ed. G.E. JONES. TOTOWA NJ: Humana Press Inc. pp. 233-262.
8. GARRETT I.R., DURIE B.G.M., NEDWIN G.E. ET AL. (1987) Production of lymphotoxin, a bone-resorbing cytokine, by cultured human myeloma cells. N. Engl. J. Med. 317, 526-532.
9. GIRASOLE G., JILKA R.L., PASSERI BADWELL S., BODER G., WILLIAMS D.C. & MANOLAGAS S. (1992) 17β Estradiol inhibits IL-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the anti osteoporotic effects of estrogens. J. Clin. Invest. 89, 883-891.
10. GOWEN M., WOOD D.D., IHRIE E.J., MCGUIRE M.K.B. & RUSSELL R.G.G. (1983) An interleukin-1 like factor stimulates bone resorption in vitro. Nature 306, 378-380.
11. GOWEN M., WOOD D.D. & RUSSELL R.G.G. (1985) Stimulation of the proliferation of human bone cells in vitro by human monocyte products with IL-1 activity. J. Clin. Invest. 75, 1223-1229.
12. JILKA R.L., HANGOC G., GIRASOLE G. ET AL. (1992) Increased osteoclast development after estrogen loss: mediation by Interleukin-6. Science 257, 88-91.
13. LORENZO J. (1998) Mice lacking the type 1 Interleukin-1 receptor do not lose bone mass after ovariectomy. Endocrinol. 139, 3022-3025.
14. MARIE P.J., HOTT M., LAUNAY J.M., GRAULET A.M. & GUERIS J. (1993) In vitro production of cytokines by bone surface-derived osteoblastic cells in normal and osteoporotic post-menopausal women: relationship with cell proliferation. J. Clin. Endocrinol. 77, 824-830.
15. PACIFICI R., RIFAS L., TEITELBAUM S. ET AL. (1987) Spontaneous release of interleukin-1 from human blood monocytes reflects bone formation in idiopathic osteoporosis. Proc. Natl. Acad. Sci. USA. 84, 4616-4620.
16. PACIFICI R., BROWN C., PUSCHECK E. ET AL. (1991) The effect of surgical menopause and estrogen replacement on cytokine release from human blood monocytes. Proc. Natl. Acad. Sci. USA. 88, 5134-5138.
17. PACIFICI R. (1996) Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis. J. Bone Miner. Res. 11 (8), 1043-1051.
18. RALSTON S. (1994) Analysis of gene expression in human bone biopsies by polymerase chain reaction: evidence for enhanced cytokine expression in postmenopausal osteoporosis. J. Bone Miner. Res. 9, 883-890.
19. SCHEVEN B.A., VISSER J.W.M. & NIJWEIDE P.J. (1986) In vitro osteoclast generation from different bone marrow fractions, including a highly enriched haematopoietic stem cell population. Nature 321, 79.
20. TASHJIAN A.H., VOELKEL E.F., LAZZARO M., GOAD D., BOSMA T. & LEVINE L. (1987) Tumour necrosis factor-α (cachectin) stimulates bone resorption in mouse calvaria via a prostaglandin-mediated mechanism. Endocrinol. 120, 2029-2036.
21. WALSH C.A., BIRCH M.A., FRASER W.D. ET AL. (1994) Primary cultures of human bone-derived cells produce parathyroid hormone-related protein: a study of 40 patients of varying age and pathology. Bone and Mineral 27, 43-50.
22. ZHENG S.X., VRINDTS Y., DE GROOTE D. ET AL. (1997) Increase in cytokine production (IL-1 beta, IL-6, TNF-alpha, but not IFN-gamma, GM-CSF or LIF) by stimulated whole blood cells in postmenopausal osteoporosis. Maturitas 26, 63-71.